Sign In
Buy IVA
$4.04
-0.0500 (-1.22%)
At Close: Jun 03, 2026
Point sur la situation de trésorerie d'Inventiva et sur le crédit conclu avec la Banque Européenne d'Investissement
04:45pm, Monday, 04'th Jul 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, États-Unis), le 4 juillet 2022 - Inventiva (Euronext Paris et Nasdaq : IVA) (la "Société "), société biopharmaceutique spécialisée dans le développem
Inventiva to host a webcast with Key Opinion Leaders following the EASL International Liver Congress™ 2022
04:00pm, Thursday, 16'th Jun 2022
Daix (France), Long Island City (New York, United States), June 16, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral s
Here's Why Inventiva S.A. Sponsored ADR (IVA) Could be Great Choice for a Bottom Fisher
01:55pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
Inventiva S.A. Sponsored ADR (IVA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisi
Here's Why Inventiva S.A. Sponsored ADR (IVA) Could be Great Choice for a Bottom Fisher
11:34am, Wednesday, 15'th Jun 2022
Inventiva S.A. Sponsored ADR (IVA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately.
Inventiva annonce la présentation de trois abstracts scientifiques lors de l’EASL International Liver Congress™ 2022
08:00pm, Thursday, 09'th Jun 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, États-Unis), le 9 juin 2022 – Inventiva (Euronext Paris et Nasdaq : IVA) (la « Société »), société biopharmaceutique spécialisée dans le développ
Inventiva announces three scientific presentations at the EASL International Liver Congress™ 2022
08:00pm, Thursday, 09'th Jun 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), June 9, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral sm
Inventiva intègre le segment Tech Leaders d’Euronext
08:00pm, Tuesday, 07'th Jun 2022 GlobeNewswire Inc.
Inventiva joins the Euronext Tech Leaders segment
08:00pm, Tuesday, 07'th Jun 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), June 7, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the de
Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Sessions of the American Diabetes Association
08:00pm, Friday, 03'rd Jun 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), June 3, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral sm
Inventiva annonce la présentation d’un abstract scientifique lors de la 82nd Scientific Sessions of the American Diabetes Association
08:00pm, Friday, 03'rd Jun 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), le 3 juin 2022 – Inventiva (Euronext Paris et Nasdaq : IVA) (la « Société »), société biopharmaceutique spécialisée dans le dévelo
Results of the votes of the Combined Shareholders’ Meeting of May 19, 2022
08:00pm, Friday, 20'th May 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), May 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral sm
Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunie le 19 mai 2022
08:00pm, Friday, 20'th May 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, Etats-Unis), le 20 mai 2022 – Inventiva (Euronext Paris et Nasdaq : IVA), société́ biopharmaceutique spécialisée dans le développement clinique de pe
Inventiva publie ses informations financières du 1er trimestre 2022 et fait un point sur ses développements cliniques
08:00pm, Monday, 16'th May 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, Etats-Unis), le 16 mai 2022 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de peti
Inventiva reports 2022 First Quarter Financial Information and provides clinical development update
08:00pm, Monday, 16'th May 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), May 16, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the de
Inventiva secures a €50 million credit facility from the European Investment Bank
06:00am, Monday, 16'th May 2022 GlobeNewswire Inc.
Daix (France), Long Island City (New York, United States), May 16, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the de
